切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2021, Vol. 17 ›› Issue (06) : 657 -662. doi: 10.3877/cma.j.issn.1673-5250.2021.06.006

论著

北京市胎儿及婴儿先天性脑积水发生情况及婴儿期转归
张雯, 徐宏燕, 张彦春, 李东阳, 刘凯波()   
  • 收稿日期:2021-06-02 修回日期:2021-11-20 出版日期:2021-12-01
  • 通信作者: 刘凯波

Epidemiological investigation of congenital hydrocephalus fetuses or infants and their prognosis among surveillance period in Beijing

Wen Zhang, Hongyan Xu, Yanchun Zhang, Dongyang Li, Kaibo Liu()   

  • Received:2021-06-02 Revised:2021-11-20 Published:2021-12-01
  • Corresponding author: Kaibo Liu
  • Supported by:
    Project of Beijing Scientific and Technological Commission(Z141100006014025)
引用本文:

张雯, 徐宏燕, 张彦春, 李东阳, 刘凯波. 北京市胎儿及婴儿先天性脑积水发生情况及婴儿期转归[J]. 中华妇幼临床医学杂志(电子版), 2021, 17(06): 657-662.

Wen Zhang, Hongyan Xu, Yanchun Zhang, Dongyang Li, Kaibo Liu. Epidemiological investigation of congenital hydrocephalus fetuses or infants and their prognosis among surveillance period in Beijing[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2021, 17(06): 657-662.

目的

通过对北京市5年先天性脑积水(CH)监测资料分析,了解北京市胎儿及婴儿的CH发生率、诊断及转归。

方法

选择2015年1月至2019年12月,北京市出生缺陷监测系统内监测对象(胎龄为13周至生后1岁)中,407例CH患儿(胎儿或婴儿)为研究对象。对其出生缺陷诊断资料进行分析。采用χ2检验,对孤立性与非孤立性CH活产儿婴儿期存活率进行统计学比较。本研究遵循的程序符合2013年新修订的《世界医学协会赫尔辛基宣言》要求。

结果

本研究时间(5年)内,北京市胎儿及1岁内婴儿的CH发生率为3.60×10-4(407/1 129 861)。这407例CH患儿中,82例(20.15%)合并颅外畸形,20例(4.91%)合并染色体异常;CH胎儿的产前诊断率为92.38%(376/407),超声检出CH胎儿时,其胎龄为24周(23~35周),其中胎龄≥28周者占26.06%(98/376)。376例产前被诊断的CH胎儿中,44例采取产前胎儿超声联合MRI检查,而且通过胎儿MRI检查对4例胎儿的颅内畸形具体类型进行了补充诊断。本研究未发现CH患儿的孕母合并宫内感染;103例CH活产儿中,73例孤立性CH患儿的婴儿期(1岁内)存活率为72.6%(53/73),高于30例非孤立性CH患儿的婴儿期存活率(60.0%,18/30),二者比较,差异无统计学意义(P>0.05)。

结论

北京市在预防出生缺陷发生的三级防控体系中,对CH胎儿与婴儿的一级、二级防控已取得效果。对孕妇全孕期多次动态胎儿超声检查,必要时联合胎儿MRI检查,对非孤立性CH胎儿同时采取细胞遗传学和分子遗传学检测,可进一步提高CH患儿的防控效果。

Objective

To explore the incidence, diagnosis and sequelae of congenital hydrocephalus (CH) fetus and infants of Beijing by analyzing monitoring data of CH in Beijing in nearly 5 years.

Methods

From January 2015 to December 2019, a total of 407 CH fetuses or infants in the Birth Defects Monitoring Network in Beijing from 13 weeks of gestation to 1 year after birth were selected as research subjects. Their birth defects diagnosis data were analyzed. Chi-square test was used to statistically compare the survival rate between isolated and non-isolated CH of live born infants within 0-1 year after birth. The procedures followed in this study were in line with World Medical Association Declaration of Helsinki revised in 2013.

Results

The incidence of CH in fetuses and infants within 1 year after birth in nearly 5 years in Beijing was 3.60×10-4 (407/1 129 861). Among 407 cases of CH fetuses or infants, 82 cases (20.15%) were complicated with extracranial malformation, and 20 cases (4.91%) were complicated with chromosome abnormalities. The prenatal diagnosis rate of CH fetus was 92.38%(376/407). When fetus diagnosed with CH by fetal ultrasound, their gestational age was 24 gestational weeks (23-35 gestational weeks), and fetus of gestational age ≥28 weeks were accounted for 26.06% (98/376) of the prenatal diagnosed cases. Among 376 CH fetuses diagnosed prenatally, 44 cases were examined by prenatal fetal ultrasound and magnetic resonance imaging (MRI), and 4 cases were diagnosed supplementary specific types of intracranial malformations by fetal MRI. No intrauterine infection of pregnant women was found in this study. Among 103 CH cases of live births, the survival rate within 1 year after birth of 73 infants with isolated CH was 72.6% (53/73), the survival rate of 30 infants with non-isolated CH was 60.0% (18/30), but the difference was not statistically significant (P>0.005).

Conclusions

In three-level prevention and control system to prevent birth defects, the primary and secondary prevention for CH fetuses or infants in Beijing has achieved results. Multiple dynamic fetal ultrasound examinations for pregnant women during pregnancy, combined with fetal MRI if necessary, and cytogenetic and molecular genetic examinations for non-isolated CH fetus may improve the prevention effects of CH.

图1 2015—2019年,北京市CH发生率折线图注:CH为先天性脑积水
[1]
Fernández-Méndez R, Richards HK, Seeley HM, et al. Current epidemiology of cerebrospinal fluid shunt surgery in the UK and Ireland (2004-2013)[J]. J Neurol Neurosurg Psychiatry, 2019, 90(7): 747-754. DOI: 10.1136/jnnp-2018-319927.
[2]
中国出生缺陷监测中心,全国妇幼卫生监测办公室. 中国出生缺陷监测系统疑难和微小畸形报告指南(试用版2012)[EB/OL]. (2012-11-01)[2021-05-15].

URL    
[3]
World Health Organization. ICD-11: International Statistical Classification of Diseases. The global standard for diagnostic health information[EB/OL]. (2021-05)[2021-05-15].

URL    
[4]
中华人民共和国国家卫生健康委员会. 预防艾滋病、梅毒和乙肝母婴传播工作规范(2020年版)[EB/OL]. (2020-11-25)[2021-05-15].

URL    
[5]
Yi L, Wan C, Deng C, et al. Changes in prevalence and perinatal outcomes of congenital hydrocephalus among Chinese newborns: a retrospective analysis based on the hospital-based birth defects surveillance system[J]. BMC Pregnancy Childbirth, 2017, 17(1): 406. DOI: 10.1186/s12884-017-1603-2.
[6]
Dewan MC, Rattani A, Mekary R, et al. Global hydrocephalus epidemiology and incidence: systematic review and Meta-analysis[J]. J Neurosurg, 2018: 1-15. DOI: 10.3171/2017.10.JNS17439.
[7]
Andersson J, Rosell M, Kockum K, et al. Prevalence of idiopathic normal pressure hydrocephalus: a prospective, population-based study[J]. PLoS One, 2019, 14(5): e0217705. DOI: 10.1371/journal.pone.0217705.
[8]
Garne E, Loane M, Addor MC, et al. Congenital hydrocephalus-prevalence, prenatal diagnosis and outcome of pregnancy in four European regions[J]. Eur J Paediatr Neurol, 2010, 14(2): 150-155. DOI: 10.1016/j.ejpn.2009.03.005.
[9]
Van den Veyver IB. Prenatally diagnosed developmental abnormalities of the central nervous system and genetic syndromes: a practical review[J]. Prenat Diagn, 2019, 39(9): 666-678. DOI: 10.1002/pd.5520.
[10]
夏秋玲,漆洪波. "2018年美国母胎医学会胎儿轻度侧脑室增宽诊断、评估、管理指南"解读[J]. 中国实用妇科与产科杂志2018, 34(11): 1238-1242. DOI: 10.19538/j.fk2018110113.
[11]
Hussamy DJ, Herrera CL, Twickler DM, et al. Number of risk factors in Down syndrome pregnancies[J]. Am J Perinatol, 2019, 36(1): 79-85. DOI: 10.1055/s-0038-1666974.
[12]
Sun Y, Zhang WY, Wang ZW, et al. Chromosomal microarray analysis vs. karyotyping for fetal ventriculomegaly: a Meta-analysis[J]. Chin Med J (Engl),[published online ahead of print, 2021Sep 20]. DOI: 10.1097/CM9.0000000000001683.
[13]
Mimaki M, Shiihara T, Watanabe M, et al. Holoprosencephaly with cerebellar vermis hypoplasia in 13q deletion syndrome: critical region for cerebellar dysgenesis within 13q32.2q34[J]. Brain Dev, 2015, 37(7): 714-718. DOI: 10.1016/j.braindev.2014.10.009.
[14]
Guo D, Shi Y, Jian W, et al. A novel nonsense mutation in the L1CAM gene responsible for X-linked congenital hydrocephalus[J]. J Gene Med, 2020, 22(7): e3180. DOI: 10.1002/jgm.3180.
[15]
Wang P, Liao H, Wang Q, et al. L1 syndrome prenatal diagnosis supplemented by functional analysis of one L1CAM gene missense variant[J]. Reprod Sci, 2021, 10.1007/s43032-021-00828-4.[published online ahead of print, 2021 Dec 16]. DOI: 10.1007/s43032-021-00828-4.
[16]
Pisapia JM, Sinha S, Zarnow DM, et al. Fetal ventriculomegaly: diagnosis, treatment, and future directions[J]. Childs Nerv Syst, 2017, 33(7): 1113-1123. DOI: 10.1007/s00381-017-3441-y.
[17]
潘长旺,张姿英,林莲莲,等. 弓形虫感染母婴传播的前瞻性研究[J]. 温州医学院学报1997, 27(4): 37-38. DOI:10.13771/j.cnki.33-1386/r.1997.04.018.
[18]
张建明,顾纯吉,宋雅雅,等. 苏州地区育龄妇女TORCH感染流行病学调查分析[J]. 中国血液流变学杂志2020, 30(4): 526-528. DOI: 10.3969/j.issn.1009-881X.2020.04.032.
[19]
Lipitz S, Yagel S, Malinger G, et al. Outcome of fetuses with isolated borderline unilateral ventriculomegaly diagnosed at mid-gestation[J]. Ultrasound Obstet Gynecol, 1998, 12(1): 23-26. DOI: 10.1046/j.1469-0705.1998.12010023.x.
[20]
Hirsch JF. Consensus: long-term outcome in hydrocephalus[J]. Childs Nerv Syst, 1994, 10(1): 64-69. DOI: 10.1007/BF00313587.
[21]
Futagi Y, Suzuki Y, Toribe Y, et al. Neurodevelopmental outcome in children with fetal hydrocephalus[J]. Pediatr Neurol, 2002, 27(2): 111-116. DOI: 10.1016/s0887-8994(02)00395-8.
[22]
Lin CT, Riva-Cambrin JK. Management of posterior fossa tumors and hydrocephalus in children: a review[J]. Childs Nerv Syst, 2015, 31(10): 1781-1789. DOI: 10.1007/s00381-015-2781-8.
[1] 武玺宁, 欧阳云淑, 张一休, 孟华, 徐钟慧, 张培培, 吕珂. 胎儿心脏超声检查在抗SSA/Ro-SSB/La抗体阳性妊娠管理中的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1056-1060.
[2] 杨水华, 何桂丹, 覃桂灿, 梁蒙凤, 罗艳合, 李雪芹, 唐娟松. 胎儿孤立性完全型肺静脉异位引流的超声心动图特征及高分辨率血流联合时间-空间相关成像的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1061-1067.
[3] 赵红娟, 赵博文, 潘美, 纪园园, 彭晓慧, 陈冉. 应用多普勒超声定量分析正常中晚孕期胎儿左心室收缩舒张时间指数[J]. 中华医学超声杂志(电子版), 2023, 20(09): 951-958.
[4] 张璟璟, 赵博文, 潘美, 彭晓慧, 毛彦恺, 潘陈可, 朱玲艳, 朱琳琳, 蓝秋晔. 胎儿超声心动图测量McGoon指数在评价胎儿肺血管发育中的应用[J]. 中华医学超声杂志(电子版), 2023, 20(08): 860-865.
[5] 旺久, 陈军, 朱霞, 米玛央金, 赵胜, 陈欣林, 李建华, 王双. 山南市妇幼保健院开展胎儿系统超声筛查的效果分析[J]. 中华医学超声杂志(电子版), 2023, 20(07): 728-733.
[6] 徐鹏, 李军, 高巍伦, 王峥, 庞珅, 李春妮, 朱霆. 快速旋转扫查法在胎儿超声心动图检查中的应用价值[J]. 中华医学超声杂志(电子版), 2023, 20(07): 761-766.
[7] 谭芳, 杨娇娇, 沈玉琴, 李炎菲海, 王海蕊, 范思涵, 纪学芹. 胎儿心脏定量分析技术对正常胎儿心脏形态及收缩功能的评价[J]. 中华医学超声杂志(电子版), 2023, 20(06): 598-604.
[8] 罗刚, 泮思林, 陈涛涛, 许茜, 纪志娴, 王思宝, 孙玲玉. 超声心动图在胎儿心脏介入治疗室间隔完整的肺动脉闭锁中的应用[J]. 中华医学超声杂志(电子版), 2023, 20(06): 605-609.
[9] 黄佳, 石华, 张玉国, 胡佳琪, 陈茜. 胎儿左头臂静脉正常与异常超声图像特征及其临床意义[J]. 中华医学超声杂志(电子版), 2023, 20(06): 610-617.
[10] 袁泽, 庄丽. 超声检测胎儿脐动脉和大脑中动脉血流对胎儿宫内窘迫的诊断价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 618-621.
[11] 刘镭, 杨昕, 许晓华, 林胜谋, 熊初琴, 农丽录, 董振宇, 李胜利. 中孕期胎儿鼻前皮肤厚度及鼻骨长度筛查胎儿染色体病的临床价值[J]. 中华医学超声杂志(电子版), 2023, 20(05): 506-510.
[12] 李博, 孔德璇, 彭芳华, 吴文瑛. 超声在胎儿肺静脉异位引流诊断中的应用价值[J]. 中华医学超声杂志(电子版), 2023, 20(04): 437-441.
[13] 杨皓媛, 龚杰, 邹青伟, 阮航. 哮喘孕妇的母婴不良妊娠结局研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 522-529.
[14] 董晓燕, 赵琪, 唐军, 张莉, 杨晓燕, 李姣. 奥密克戎变异株感染所致新型冠状病毒感染疾病新生儿的临床特征分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 595-603.
[15] 李运林, 娄冬华. 滨海县非酒精性脂肪肝发病与消退的影响因素分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 354-358.
阅读次数
全文


摘要